1.
Bimekizumab Maintenance of Response at Every Visit Over 4 Years in Patients with Psoriasis Achieving Clear Skin at Week 16: Results from Four Phase 3 Trials. J of Skin. 2025;9(2):s526. doi:10.25251/skin.10.supp.526